Natixis Advisors LLC Has $16.58 Million Holdings in Ventas, Inc. $VTR

Natixis Advisors LLC lessened its holdings in shares of Ventas, Inc. (NYSE:VTR) by 6.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 214,234 shares of the real estate investment trust’s stock after selling 14,017 shares during the quarter. Natixis Advisors LLC’s holdings in Ventas were worth $16,578,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after buying an additional 2,349,176 shares during the period. JPMorgan Chase & Co. raised its stake in Ventas by 1.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after buying an additional 387,495 shares during the period. State Street Corp raised its stake in Ventas by 3.3% during the 3rd quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock worth $2,038,176,000 after buying an additional 928,386 shares during the period. Geode Capital Management LLC raised its stake in Ventas by 3.8% during the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in Ventas by 2.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 6,601,143 shares of the real estate investment trust’s stock worth $462,002,000 after buying an additional 160,998 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Citigroup raised their price objective on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Scotiabank raised their price objective on Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Thursday, May 21st. The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price target on shares of Ventas in a research note on Tuesday, May 19th. UBS Group lifted their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Finally, Morgan Stanley set a $90.00 price target on Ventas in a research note on Friday, February 13th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Ventas Stock Performance

VTR opened at $82.13 on Friday. The business’s 50-day moving average price is $85.05 and its two-hundred day moving average price is $82.36. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $91.06. The company has a market capitalization of $39.93 billion, a price-to-earnings ratio of 149.33, a P/E/G ratio of 1.75 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business earned $0.84 EPS. The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts expect that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insider Activity

In other news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.53% of the stock is owned by company insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.